Interpace Biosciences IDXG
OTC IDXG
$5.40 +0.15 (+2.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Interpace Biosciences (IDXG) Long-Term Debt Issuances (2021)

Updated

Interpace Biosciences' Long-Term Debt Issuances came in at $2 million for FY2022, down 73.3% from $7.5 million in FY2021.

Analysis

Interpace Biosciences (IDXG) Long-Term Debt Issuances (2021) Analysis & Trends

  • Per Business Quant, earlier years put Long-Term Debt Issuances at $7.5 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 HCA Healthcare 103.18 Bn 99.19 Bn - 2.99 Bn
2 Natera 57.81 Bn 53.49 Bn 485.19 Mn -
3 Labcorp Holdings 26.94 Bn 24.69 Bn 1.11 Bn 175.00 Mn
4 Quest Diagnostics 26.85 Bn 24.98 Bn 1.03 Bn 494.00 Mn
5 Guardant Health 22.51 Bn 18.57 Bn 219.03 Mn -
6 Tenet Healthcare 22.37 Bn 11.37 Bn - 14.00 Mn
7 Fresenius Medical Care AG 13.20 Bn 5.15 Bn 1.52 Bn 121.81 Mn
8 BrightSpring Health Services 12.39 Bn 10.72 Bn 492.75 Mn -
9 Encompass Health 12.26 Bn 11.92 Bn - 750.00 Mn
10 Interpace Biosciences 180.06 Mn 170.78 Mn 5.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 8.00 Mn
Jun 30, 2021 2.50 Mn
Mar 31, 2021 5.00 Mn
API Access

Interpace Biosciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=IDXG&period=max&api_key=YOUR_API_KEY